Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| AIDS Vaccines | 5 | 2018 | 452 | 0.64 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 3 | 2017 | 154 | 0.46 | Why? |
| Simian Immunodeficiency Virus | 3 | 2017 | 251 | 0.43 | Why? |
| HIV-1 | 7 | 2018 | 3365 | 0.38 | Why? |
| Macaca mulatta | 9 | 2021 | 3716 | 0.37 | Why? |
| Immunity, Cellular | 9 | 2021 | 3614 | 0.37 | Why? |
| HIV Antibodies | 3 | 2018 | 776 | 0.25 | Why? |
| Vaccines, DNA | 2 | 2020 | 871 | 0.23 | Why? |
| Immunity, Humoral | 9 | 2021 | 4849 | 0.22 | Why? |
| Antibodies, Neutralizing | 12 | 2021 | 25288 | 0.22 | Why? |
| Gene Products, env | 2 | 2017 | 74 | 0.21 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 386 | 0.21 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.17 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.17 | Why? |
| Germinal Center | 1 | 2017 | 332 | 0.14 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.13 | Why? |
| Milk, Human | 1 | 2021 | 956 | 0.12 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 533 | 0.12 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.09 | Why? |
| Adenoviridae | 3 | 2018 | 1151 | 0.09 | Why? |
| HIV Infections | 3 | 2018 | 11620 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2021 | 2309 | 0.08 | Why? |
| Genetic Vectors | 3 | 2018 | 1600 | 0.08 | Why? |
| Immunization, Secondary | 3 | 2020 | 1649 | 0.08 | Why? |
| Animals | 11 | 2021 | 78931 | 0.07 | Why? |
| Double-Blind Method | 3 | 2021 | 5988 | 0.07 | Why? |
| Nasal Mucosa | 2 | 2020 | 1218 | 0.06 | Why? |
| Disease Models, Animal | 4 | 2020 | 10998 | 0.06 | Why? |
| Antibodies, Monoclonal | 2 | 2020 | 8041 | 0.06 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2020 | 1267 | 0.05 | Why? |
| Neutralization Tests | 3 | 2020 | 6698 | 0.05 | Why? |
| Binding, Competitive | 1 | 2020 | 264 | 0.05 | Why? |
| Vaccine Potency | 1 | 2021 | 339 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| Mutant Proteins | 1 | 2020 | 328 | 0.05 | Why? |
| Lactation | 1 | 2021 | 361 | 0.05 | Why? |
| Immunologic Memory | 2 | 2020 | 3362 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.04 | Why? |
| Back Pain | 1 | 2018 | 115 | 0.04 | Why? |
| Guinea Pigs | 1 | 2018 | 420 | 0.04 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.04 | Why? |
| Dizziness | 1 | 2018 | 275 | 0.04 | Why? |
| Vaccinia virus | 1 | 2018 | 346 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Placebos | 1 | 2018 | 629 | 0.04 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.04 | Why? |
| Nose | 1 | 2021 | 1093 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.03 | Why? |
| Virus Replication | 3 | 2021 | 14331 | 0.03 | Why? |
| Primates | 1 | 2017 | 584 | 0.03 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Abdominal Pain | 1 | 2018 | 858 | 0.03 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2018 | 1394 | 0.03 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.03 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Vaccination | 3 | 2020 | 19050 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.02 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Fatigue | 1 | 2018 | 2479 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Humans | 10 | 2021 | 930598 | 0.02 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Immunization, Passive | 1 | 2017 | 10067 | 0.01 | Why? |
| Mice | 1 | 2020 | 21357 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Nkolola's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(199)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_